SCHEMBL1111908

SCHEMBL1111908

CCCNCSc1cccs1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 1/20 0.42
HPGD P15428 2/20 0.39
MAPT P10636 2/20 0.39
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
ALDH1A1 P00352 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HTT P42858 2/20 0.34
GAA P10253 1/20 0.34
HDAC3 O15379 1/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
HDAC1 Q13547 1/20 0.32
HDAC11 Q96DB2 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
HSD17B3 P37058 1/20 0.31
TAS1R3 Q7RTX0 1/20 0.31
TAS1R1 Q7RTX1 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6468979 0.84 FBP1 (0.41) FBP1HPGDMAPTNPC1RAB9A
SCHEMBL10365892 0.75
SCHEMBL3852818 0.74
Ammonia Solution, Strong SCHEMBL7247507 0.73 FBP1 (0.48) FBP1HPGDMAPTNPC1RAB9A
SCHEMBL425181 0.72 FBP1 (0.46) FBP1HPGDMAPTNPC1RAB9A
SCHEMBL9724074 0.70 FBP1 (0.45) FBP1HPGDMAPTNPC1RAB9A
SCHEMBL1111711 0.69 ALDH1A1 (0.44) HPGDMAPTNPC1RAB9AALDH1A1
SCHEMBL20669518 0.69 FBP1 (0.43) FBP1HPGDMAPTALDH1A1SMN1; SMN2
SCHEMBL5315566 0.69 FBP1 (0.43) FBP1HPGDMAPTALDH1A1SMN1; SMN2
SCHEMBL28390983 0.69 FBP1 (0.43) FBP1HPGDMAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2279174-A2 ARYLSULFONAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE Genentech, Inc. (US) 2011-02-02 EP disclosed
WO-2009143246-A2 ARYLSULFONAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE GENENTECH, INC. (US) 2009-11-26 WO disclosed
EP-1685119-A1 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS Abbott Laboratories (US) 2006-08-02 EP disclosed
WO-2005049593-A2 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2005-06-02 WO disclosed
WO-2005049594-A1 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2005-06-02 WO disclosed